The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 622.e17-622.e28

  van den Kommer, Tessa N ^a   Dik, Miranda G ^a   Comijs, Hannie C ^a   Lütjohann, Dieter ^b   Lips, Paul ^a   Jonker, Cees ^a   Deeg, Dorly J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

ApoE e4; Cholesterol precursors; Extracerebral cholesterol homeostasis; Longitudinal population based study; Plant sterols; Trajectory of cognitive functioning

Indexed keywords

26 HYDROXYCHOLESTEROL; APOLIPOPROTEIN E4; CAMPESTEROL; CHOLESTEROL; LANOSTEROL; LATHOSTEROL; SITOSTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; HOMEOSTASIS; HUMAN; INFORMATION PROCESSING; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NONLINEAR SYSTEM; PRIORITY JOURNAL;

EID: 84855808674     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.02.019     Document Type: Article

References (42)

1. Abbott R.D., Sharp D.S., Burchfiel C.M., Curb J.D., Rodriguez B.L., Hakim A.A., Yano K. Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Ann. Epidemiol 1997, 7:417-424.
2. Anstey K.J., Lipnicki D.M., Low L.F. Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 2008, 16:343-354.
3. Beekman A.T., Deeg D.J., van Limbeek J., Braam A.W., de Vries M.Z., van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol. Med 1997, 27:231-235.
4. Bremmer M.A., Hoogendijk W.J., Deeg D.J., Schoevers R.A., Schalk B.W., Beekman A.T. Depression in older age is a risk factor for first ischemic cardiac events. Am. J. Geriatr. Psychiatry 2006, 14:523-530.
5. Deeg D.J., van Tilburg T., Smit J.H., de Leeuw E.D. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. J. Clin. Epidemiol 2002, 55:319-328.
6. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., van Kamp G.J., Deeg D.J. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology 2000, 54:1492-1497.
7. Dullemeijer C., Durga J., Brouwer I.A., van de Rest O., Kok F.J., Brummer R.J., van Boxtel M.P., Verhoef P. N 3 Fatty acid proportions in plasma and cognitive performance in older adults. Am. J. Clin. Nutr 2007, 86:1479-1485.
8. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997, 96:37-43.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
10. Grundy S.M. George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler. Thromb 1991, 11:1619-1635.
11. Gylling H., Strandberg T., Tilvis R., Miettinen T.A. Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler. Thromb. Vasc. Biol 1994, 14:694-700.
12. Hascalovici J.R., Vaya J., Khatib S., Holcroft C.A., Zukor H., Song W., Arvanitakis Z., Bennett D.A., Schipper H.M. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J. Neurochem 2009, 110:1241-1253.
13. Havekes L.M., de Knijff P., Beisiegel U., Havinga J., Smit M., Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid Res 1987, 28:455-463.
14. Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol 2009, 66:343-348.
15. Heverin M., Bogdanovic N., Lütjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., Björkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 2004, 45:186-193.
16. Jolles J., Verhey F.R., Riedel W.J., Houx P.J. Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies. Drugs Aging 1995, 7:459-479.
17. Kölsch H., Heun R., Kerksiek A., von Bergmann K., Maier W., Lütjohann D. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 2004, 368:303-308.
18. Kriegsman D.M.W., Penninx B.W.J.H., Eijk-Van J., Boeke A.J.P., Deeg D.J.H. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinations of inaccuracy. J. Clin. Epidemiol 1996, 49:1407-1417.
19. Law M. Plant sterol and stanol margarines and health. BMJ 2000, 320:861-864.
20. Lütjohann D., Brzezinka A., Barth E., Abramowski D., Staufenbiel M., von Bergmann K., Beyreuther K., Multhaup G., Bayer T.A. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 2002, 43:1078-1085.
21. Miettinen T.A., Tilvis R.S., Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 1990, 131:20-31.
22. Moller J.T., Cluitmans P., Rasmussen L.S., Houx P., Rasmussen H., Canet J., Rabbitt P., Jolles J., Larsen K., Hanning C.D., Langeron O., Johnson T., Lauven P.M., Kristensen P.A., Biedler A., van Beem H., Fraidakis O., Silverstein J.H., Beneken J.E., Gravenstein J.S. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998, 351:857-861. ISPOCD investigators.
23. Nissinen M.J., Gylling H., Miettinen T.A. Effects of dietary cholesterol and fat on serum non-cholesterol sterols according to different apolipoprotein E subgroups among healthy men. Br. J. Nutr 2008, 100:373-379.
24. Piccinin A.M., Rabbitt P.M. Contribution of cognitive abilities to performance and improvement on a substitution coding task. Psychol. Aging 1999, 14:539-551.
25. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem 1987, 262:14352-14360.
26. Plat J., Mensink R.P. Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk. Nutr. Metab. Cardiovasc. Dis 2001, 11:31-40.
27. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J. Psychiatry Neurosci 1996, 21:128-134.
28. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas 1977, 1:385-401.
29. Reinhard O., Rood-Bakker D. Alcoholgebruik in beeld. Standaardmeetlat 1998, Nederlands Economisch Instituut, Rotterdam (in Dutch).
30. Rey A. L'examen clinique en psychologie 1964, Presses Universitaire de France, Paris.
31. Schiepers O.J., de Groot R.H., van Boxtel M.P., Jolles J., de Jong A., Lütjohann D., Plat J., Mensink R.P. Consuming functional foods enriched with plant sterol or stanol esters for 85 weeks does not affect neurocognitive functioning or mood in statin-treated hypercholesterolemic individuals. J. Nutr. 2009, 139:1368-1373.
32. Solomon A., Kåreholt I., Ngandu T., Winblad B., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 2007, 68:751-756.
33. Solomon A., Leoni V., Kivipelto M., Besga A., Oksengård A.R., Julin P., Svensson L., Wahlund L.O., Andreasen N., Winblad B., Soininen H., Björkhem I. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci. Lett. 2009, 462:89-93.
34. Sudhop T., Lütjohann D., Kodal A., Igel M., Tribble D.L., Shah S., Perevozskaya I., von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002, 106:1943-1948.
35. Teunissen C.E., de Vente J., von Bergmann K., Bosma H., van Boxtel M.P., De Bruijn C., Jolles J., Steinbusch H.W., Lütjohann D. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol. Aging 2003, 24:147-155.
36. Thelen K.M., Falkai P., Bayer T.A., Lütjohann D. Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci. Lett. 2006, 403:15-19.
37. Van de Rest O., Spiro A., Krall-Kaye E., Geleijnse J.M., de Groot L.C., Tucker K.L. Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. J. Nutr 2009, 139:2329-2336.
38. Van den Kommer T.N., Comijs H.C., Dik M.G., Jonker C., Deeg D.J. Development of classification models for early identification of persons at risk for persistent cognitive decline. J. Neurol 2008, 255:1486-1494.
39. Van den Kommer T.N., Dik M.G., Comijs H.C., Fassbender K., Lütjohann D., Jonker C. Total cholesterol and oxysterols: early markers for cognitive decline in elderly?. Neurobiol. Aging 2009, 30:534-545.
40. Van den Kommer T.N., Dik M.G., Comijs H.C., Jonker C., Deeg D.J. The role of lipoproteins and inflammation in cognitive decline: do they interact?. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging. 2010.05.024.
41. Van Gelder B.M., Tijhuis M., Kalmijn S., Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr 2007, 85:1142-1147.
42. Weingärtner O., Lütjohann D., Böhm M., Laufs U. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. Atherosclerosis 2010, 210:362-365.